Genetic Test Evaluation

understanding how genetic tests impact patient management

Oncotype DX Colon Recurrence Score test (Genomic Health Inc.)

March 12, 2018

This report evaluates the analytical validity, clinical validity, and clinical utility of the Oncotype DX Colon Recurrence Score test, a gene expression assay intended to quantify the risk of disease recurrence in patients with anatomic stage II, mismatch repair proficient (MMR-P) or stage III A/B colon cancer.